BACK TO TOP
KSE100
177,382.57
610.39
(0.35%)
KSE100PR
52,412.25
180.35
(0.35%)
ALLSHR
106,289.82
141.72
(0.13%)
KSE30
51,822.39
245.89
(0.48%)
KMI30
255,823.27
1649.18
(0.65%)
BKTI
48,432.52
109.40
(0.23%)
OGTI
35,759.50
-46.88
(-0.13%)
KMIALLSHR
68,759.73
47.95
(0.07%)
PSXDIV20
81,338.92
172.84
(0.21%)
UPP9
64,098.12
696.49
(1.10%)
NITPGI
47,890.77
363.43
(0.76%)
NBPPGI
51,365.48
315.36
(0.62%)
MZNPI
32,172.39
308.64
(0.97%)
JSMFI
40,207.59
-178.06
(-0.44%)
ACI
22,582.84
57.83
(0.26%)
JSGBKTI
75,251.40
95.52
(0.13%)
HBLTTI
19,418.93
19-11-2026
6.32
(0.03%)
MII30
23,217.99
125.17
(0.54%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.350.95
-3.44
(-0.97%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Nov 20, 2026 4:48 PM
REG
DFC
CSF
ODL
Open
359.00
High
360.00
Low
350.00
Volume
1,587
CIRCUIT BREAKER
318.95 — 389.83
DAY RANGE
350.00 — 360.00
52-WEEK RANGE ^
293.01 — 475.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
354.39
VAR
18.00
HAIRCUT
22.50
P/E Ratio (TTM) **
22.18
1-Year Change * ^
-12.04%
YTD Change * ^
-6.60%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Amna Piracha KhanChairperson
Zain RazaCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

M/s Taseer Hadi Khalid & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
15,255,463.45
Shares
43,469,051
Face Value
10.00
Free Float
17,387,621
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2026Transmission of Quarterly Financial Statements for the Period Ended 30-09-2026 View   PDF
Oct 29, 2026Financial Results for the Quarter Ended 30-09-2026 View   PDF
Oct 7, 2026Transmission of Annual Report for the Year Ended 30-06-2026 View   PDF
Sep 29, 2026Financial Results for the Year Ended 2026-06-30 View   PDF
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31-03-2026 View   PDF
DateTitleDocument
Oct 28, 2026Certified True Copies of the Resolutions passed at the 70th Annual General Meeting of the Company View   PDF
Oct 21, 2026Board Meeting View   
Oct 7, 2026Notice of Annual General Meeting View   PDF
Oct 6, 2026Notice of Annual General Meeting prior to publication View   PDF
Sep 22, 2026Board Meeting View   
DateTitleDocument
Nov 16, 2026Change in Name of External Auditors View   
Nov 6, 2026Credit of final cash dividend View   
Nov 2, 2026Change of Company Secretary View   
Nov 2, 2026Company Secretary View   
Sep 17, 2026Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales15,757,02413,857,96712,711,7149,893,391
Profit after Taxation650,902528,243400,054189,042
EPS14.9712.159.204.35
Q1 2027Q3 2026Q2 2026Q1 2026
Sales4,772,8623,659,6864,405,7813,883,252
Profit after Taxation219,643150,250171,195182,420
EPS5.053.463.934.20
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)42.0541.2738.8838.63
Net Profit Margin (%)4.133.813.151.91
EPS Growth (%)23.2132.07111.49(63.23)
PEG1.161.000.24(0.50)

Payouts

Financial Reports